
- Volume 0 0
Obesity Beneficial in Patients with Heart Failure
A study out of Yale University concluded that overweight and obese people with heart failure have a lower risk of mortality than normal or underweight patients. While previous studies have examined the protective effect of obesity in patients with heart failure, this study is the largest to date and included heart failure in various degrees of severity.As reported in the Archives of Internal Medicine, this study included 7767 patients with stable heart failure who were divided into groups of underweight, healthy weight, overweight, and obese. Researchers followed these patients for an average of 3 years and found that obese and overweight patients were 19% and 12% less likely to die, respectively, than patients of a healthy weight. Further, underweight patients were 21% more likely to die. The authors theorized that overweight and obese patients had better outcomes because their weight problems created a red flag for their physicians and caused them to be diagnosed sooner. They go as far as to suggest that, until further research has been concluded, patients with heart failure should not try to lose weight.
Ms. Farley is a freelance medical writer based in Wakefield, RI.
Articles in this issue
over 20 years ago
Heart Patients Get More Appropriate Rx Treatment from Cardiologistsover 20 years ago
Surgeon General Report Blasts Rx Drug Importing Practicesover 20 years ago
Mevacor a Pharmacist-Only OTC? No Way, Advisory Group Tells FDAover 20 years ago
Expo Focuses on Caregiver Needsover 20 years ago
Early-Month Rx Fatalities Linked to Overworked Pharmacistsover 20 years ago
Feds Report Rx Expenditures Rose More Slowly in 2004over 20 years ago
Rx.com Offers Alternative to PBM Mail Orderover 20 years ago
Americans Rate US Health Care as Poorover 20 years ago
Pharmacy Security Combo Pack Now Availableover 20 years ago
IOM Advocates Tougher Supplement StandardsNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.